# OptiBiotix Health Appointment of Sales and Marketing Director

- Link: https://www.directorstalkinterviews.com/optibiotix-health-appointment-sales-marketing-director/412721338
- Published: 2017-01-18T07:22:55+00:00
- Author: Giles Arbor

**OptiBiotix Health plc** (LON:OPTI), a life sciences business developing compounds
to tackle obesity, high cholesterol, diabetes and skin care, announced today the
appointment of Christina Wood as Sales and Marketing Director. Christina will join
the Board subject to completion of the normal regulatory due diligence.

Christina has over 20 years’ sales experience within the food, nutrition, and nutraceuticals
industry. As the owner and CEO of Confoco, a supplier of high quality food ingredients
worldwide, Christina grew the business from £1m to £10m sales by obtaining strategic
supplier status with multiple global corporates including Nestlé, Danone, and Heinz.
During this time, she developed a network of agents and distributors across key 
international markets. Christina sold her company to Diana Naturals in 2013 which
was subsequently acquired by Symrise AG for US$1.75 billion in 2014. She joined 
John Morley, a leading food industry supplier, in late 2014 where as Director of
Sales and Marketing, she was responsible for key consumer accounts including Sainsbury’s,
Waitrose, M&S and Tesco.

She has been a finalist for Director of the Year for ‘SME and International Trade’
on two occasions and has been awarded the Nutricia Partners in Growth Award. Christina
is fluent in German and Spanish.

Christina has extensive experience in building and managing supply chain agreements
across international markets with leading industry players, and has both business
to business, and business to retail sales experience. Her sales and marketing experience
within the food, nutrition, and nutraceuticals industry and network of global contacts
will help grow revenues of OptiBiotix’s products across multiple application areas
and international markets.

> **Stephen O’Hara, CEO of OptiBiotix Health Plc, commented:** “Christina’s experience
> of building sales in her own business by developing relationships with food ingredient
> manufacturers and major retailers brings new elements of operational, commercial
> and industry expertise to OptiBiotix. Her skills in building and managing international
> networks of agents and distributors will be invaluable in taking OptiBiotix’s 
> patented SlimBiome® technology for hunger free weight loss and its LP-LDL® probiotic
> strain for cholesterol and hypertension reduction into overseas markets. This 
> will help create multiple revenue streams from OptiBiotix’s growing pipeline of
> products.”

Share on: